Skip to main content
Top
Published in: Cancer Causes & Control 3/2013

01-03-2013 | Letter to the Editor

An hypothesis on the presumed association between thyroid goiter and gastric cancer

Authors: Donald E. Henson, Jorge Albores-Saavedra

Published in: Cancer Causes & Control | Issue 3/2013

Login to get access

Excerpt

Epidemiologists have long suspected on the basis of ecological studies a relationship between the incidence of gastric cancer and iodine-deficient goiter. This relation was initially put forward by Percy Stocks in 1925 who noted that countries in Europe that had the highest prevalence of goiter also had the highest cancer mortality [1]. In the United States, a correlation was also noted between the prevalence of goiter and mortality from gastric cancer. Seventy years ago, the highest incidence of gastric cancer in the United States was found in the upper Midwest, especially in Wisconsin, the Dakotas, Minnesota, and around the Great Lakes [2]. In this part of the country, the soil has a low concentration of iodine. As expected, the incidence of iodine-deficient goiter was highest in the same region, especially near the Great Lakes. Historically, before the supplementation of table salt with iodine, this region was described as the “goiter belt.” In the Chicago area, between 1936 and 1948, the estimated prevalence of goiter was nearly three times the prevalence reported on the Atlantic Coast based on the number of hospital admissions [3]. However, despite these associations, it was not possible to ascribe causation because of the bias and population heterogeneity inherent in ecological studies [4]. …
Literature
1.
go back to reference Stocks P (1924) Cancer and goitre. Biometrika 16:364–401 Stocks P (1924) Cancer and goitre. Biometrika 16:364–401
2.
go back to reference Haenszel W (1958) Variation in the incidence of and mortality from stomach cancer with particular reference to the United States. J Natl Cancer Inst 21:213–262PubMed Haenszel W (1958) Variation in the incidence of and mortality from stomach cancer with particular reference to the United States. J Natl Cancer Inst 21:213–262PubMed
3.
go back to reference Cole WH, Slaughter DP, Marjarakis JD (1949) Carcinoma of the thyroid gland. Surg Gynec Obstet 89:349–356PubMed Cole WH, Slaughter DP, Marjarakis JD (1949) Carcinoma of the thyroid gland. Surg Gynec Obstet 89:349–356PubMed
4.
go back to reference Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology. Lippincott Williams & Wilkins, Philadelphia, pp 511–531 Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology. Lippincott Williams & Wilkins, Philadelphia, pp 511–531
5.
go back to reference Venturi S, Donati FM, Venturi A et al (2000) Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Path 4:11–17PubMed Venturi S, Donati FM, Venturi A et al (2000) Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Path 4:11–17PubMed
6.
go back to reference Lin S-W, Fan J-H, Sanford M et al (2011) Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort. Int J Cancer 129:2284–2289PubMedCrossRef Lin S-W, Fan J-H, Sanford M et al (2011) Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort. Int J Cancer 129:2284–2289PubMedCrossRef
7.
go back to reference Abnet CC, Fan JH, Kamangar F et al (2006) Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer 119:1508–1510PubMedCrossRef Abnet CC, Fan JH, Kamangar F et al (2006) Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer 119:1508–1510PubMedCrossRef
8.
go back to reference Brown-Grant K (1961) Extrathyroidal iodide concentrating mechanisms. Physiol Rev 41:189–213 Brown-Grant K (1961) Extrathyroidal iodide concentrating mechanisms. Physiol Rev 41:189–213
9.
go back to reference Elsei R, Mariotti S, Swillens S et al (1990) Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an eptiope shared between the thyroid and the gastric parietal cell. Autoimmunity 8:65–70CrossRef Elsei R, Mariotti S, Swillens S et al (1990) Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an eptiope shared between the thyroid and the gastric parietal cell. Autoimmunity 8:65–70CrossRef
10.
11.
go back to reference Aadland E, Schrumpf E, Fausa O et al (1987) Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 22:655–664PubMedCrossRef Aadland E, Schrumpf E, Fausa O et al (1987) Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 22:655–664PubMedCrossRef
12.
go back to reference Ross AP, Braasch JW (1973) Ulcerative colitis and carcinoma of the proximal bile ducts. Gut 14:94–97PubMedCrossRef Ross AP, Braasch JW (1973) Ulcerative colitis and carcinoma of the proximal bile ducts. Gut 14:94–97PubMedCrossRef
13.
go back to reference Ritchie JK, Allan RN, Macartney J, Thompson H, Hawley PR, Cooke WT (1974) Biliary tract carcinoma associated with ulcerative colitis. Q J Med 43:263–279PubMed Ritchie JK, Allan RN, Macartney J, Thompson H, Hawley PR, Cooke WT (1974) Biliary tract carcinoma associated with ulcerative colitis. Q J Med 43:263–279PubMed
14.
go back to reference Haworth AC, Manley PN, Groll A, Pace R (1989) Bile duct carcinoma and biliary tract dysplasia in chronic ulcerative colitis. Arch Pathol Lab Med 113:434–436PubMed Haworth AC, Manley PN, Groll A, Pace R (1989) Bile duct carcinoma and biliary tract dysplasia in chronic ulcerative colitis. Arch Pathol Lab Med 113:434–436PubMed
15.
go back to reference Mandal A, Dasgupta A, Jeffers L et al (1994) Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 106:185–192PubMed Mandal A, Dasgupta A, Jeffers L et al (1994) Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 106:185–192PubMed
16.
go back to reference Duerr RH, Targan SR, Landers CJ et al (1991) Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100:1385–1391PubMed Duerr RH, Targan SR, Landers CJ et al (1991) Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100:1385–1391PubMed
17.
go back to reference Wilders-Truschnig MM, Kabel PJ, Dexhage HA et al (1989) Intrathyroid dendritic cells, epithelioid cells, and giant cells in iodine deficient goiter. Am J Pathol 135:219–225PubMed Wilders-Truschnig MM, Kabel PJ, Dexhage HA et al (1989) Intrathyroid dendritic cells, epithelioid cells, and giant cells in iodine deficient goiter. Am J Pathol 135:219–225PubMed
18.
go back to reference Imai T, Kubo T, Watanabe H (1971) Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma. J Natl Cancer Inst 47:179–195PubMed Imai T, Kubo T, Watanabe H (1971) Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma. J Natl Cancer Inst 47:179–195PubMed
Metadata
Title
An hypothesis on the presumed association between thyroid goiter and gastric cancer
Authors
Donald E. Henson
Jorge Albores-Saavedra
Publication date
01-03-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 3/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0135-3

Other articles of this Issue 3/2013

Cancer Causes & Control 3/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine